Skip to content

Evolution and Adaptation to Caregiver of a Socio-geriatric Evaluation

Socio-geriatric Evaluation (ESOGER): A Clinical Tool in Telehealth to Fight Against Vulnerable Seniors's Health Alterations and Social Isolation

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05062590
Acronym
ESOGER
Enrollment
260
Registered
2021-09-30
Start date
2022-04-04
Completion date
2026-03-31
Last updated
2024-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Isolation, Aging

Brief summary

With the COVID-19 pandemic, elderly people (EP) living at home have seen their health deteriorated, thus increasing their needs in support and care. Indeed, while it was estimated that before the pandemic120 000 unattended living at home EP required care and services (taking bath, access to medication and food, etc.), the number doubled after COVID-19. Therefore, the waiting list for socio-medical services for unattended vulnerable clientele without a family doctor grew from 1300 à 1715 EP in a couple of months during the pandemic. With these numbers, it becomes clear that an intervention is needed. Truly, the Institut National d'Excellence en Santé et Services Sociaux (INESSS) conclude that it was pivotal to first identify the most vulnerable EP and second re-orient them according to their needs. Thus the investigator developed the Évaluation et orientation SOcio-GÉRiatrique (ESOGER) questionnaire available on a secure digital plateform enabling both a rapid evaluation and intervention to asses EP needs and provide the adequate ressources. Investigator's previous research has demonstrated that ESOGER is one of the rare clinical tools of first contact in telehealth while being global, multidimensional, and equitable. For this study, the investigator aims to evaluate the effect of ESOGER on EP physical and mental health, loss of autonomy, social isolation, quality of life and ressources consumption.

Interventions

Ressources recommendations and interventions curated to the needs of the EP such as refering them to a social activity for socially isolated EP

Sponsors

Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 65 and more * Living at home on the territory CIUSSS-Centre-Sud de l'île-de-Montréal (CCSMTL) of Jeanne-Mance * Brief Geriatric Assessment (BGA) score of 1/14 or more defining a severly to milidly frail health.

Exclusion criteria

* Principal address outside of the CCSMTL's Jeanne-Mance territory * Participate at another clinical trial, to avoid interferences * Not understand written or spoken French or English, questionnaires are only available in French and English.

Design outcomes

Primary

MeasureTime frameDescription
Social health3 monthsIssues related to medication and food delivery and access to home care. Presence or not of a shortage in food, medication and home care ( binary question)
COVID-19 symptoms3 monthspresence or not of fever, cough, and shortness of breath (binary question)
psychological fraility3 monthsAnxiety verbal analogic scale, score from 0= no anxiety to 10= extremly anxious
Autonomy3 monthsADL scale score from 0= very dependent to 6= very independent and IADL scale score 0= not autonomous 4= autonomous.
Socio-economic characteristics3 monthsPresence or not of socio-economic problems (binary questions)
Participant's Quality of life3 monthsMeasured by the EQ-5D scale with two parts, scale 1 score from 1= no problem to 5 ( sever health problems) and scale 2 visual analogic scale score from 0= worst possible health to 100= best possible health.

Secondary

MeasureTime frameDescription
Caregiver burden3 monthsBased on Zarit scale, score from 0= no burden to 16= high caregiver burnder

Countries

Canada

Contacts

Primary ContactOlivier Beauchet, MD
olivier.beauchet@umontreal.ca514-340-3540

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026